Register for citation alerts
"Automated central vascular access devices (ACVADs) using ultrasound and robotics are being developed" Boice et al (2022).
Development of automated central vascular access devices

Abstract:

Access to the central vasculature is critical for hemodynamic monitoring and for delivery of life-saving therapeutics during emergency medicine and battlefield trauma situations but requires skill often unavailable in austere environments. Automated central vascular access devices (ACVADs) using ultrasound and robotics are being developed. Here, we present an ex vivo lower-body porcine model as a testing platform for evaluation of vascular devices and compare its features to commercially available platforms. While the commercially available trainers were simpler to set-up and use, the scope of their utility was limited as they were unable to provide realistic anatomic, physiologic, and sonographic properties that were provided by the ex vivo model. However, the ex vivo model was more cumbersome to set-up and use. Overall, both have a place in the development and evaluation pipeline for ACVADs before testing on live animals, thus accelerating product development and translation.

Reference:

Boice EN, Berard D, Hernandez Torres SI, Avital G, Snider EJ. Development and Characterization of an Ex Vivo Testing Platform for Evaluating Automated Central Vascular Access Device Performance. J Pers Med. 2022 Aug 5;12(8):1287. doi: 10.3390/jpm12081287. PMID: 36013236; PMCID: PMC9410168.